Interpretation of an Extended Autoantibody Profile in a Well‐Characterized Australian Systemic Sclerosis (Scleroderma) Cohort Using Principal Components Analysis

Abstract

Five major autoantibody clusters with specific clinical and serologic associations were identified in Australian SSc patients. Subclassification and disease stratification using autoantibodies may have clinical utility, particularly in early disease.